Keros Therapeutics Inc (KROS) Annual Income Statement (USD)
KROS Quarterly Financials (USD)
Frequently Asked Questions About Keros Therapeutics Inc (KROS) Stock
Keros Therapeutics Inc's (KROS) last reported annual revenue was USD 3.55 Million.
Keros Therapeutics Inc's (KROS) annual revenue growth rate based on the revenue reported in the past 5 years is : -18.71%
Keros Therapeutics Inc's(KROS) is not profitable as of its last reported annual financials.
The net profit margin for Keros Therapeutics Inc's(KROS) from its laster reported year is -5277.55%
The return on equity (ROE) for Keros Therapeutics Inc's(KROS) from its last reported annual financials is : -41.46%
The return on assets (ROA) for Keros Therapeutics Inc's(KROS) from its last reported annual financials is : -26.73%
The return on invested capital (ROIC) for Keros Therapeutics Inc's(KROS) from its last reported annual financials is : -46.72%
The Debt to Equity ratio for Keros Therapeutics Inc's(KROS) from its last reported annual financials is : 0.00%
The dividend yield for Keros Therapeutics Inc's(KROS) from its laster reported year is 0.00%
Keros Therapeutics Inc's(KROS) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for KROS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
